The Cohort for Childhood Origin of Asthma and allergic diseases (COCOA) study: design, rationale and methods

Hyeon-Jong Yang, So-Yeon Lee, Dong In Suh

  • 1Department of Pediatrics, Childhood Asthma Atopy Center, Research Center for Standardization of Allergic Diseases, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, 760, Korea. jooshil@korea.kr.

Insights

The COhort for Childhood Origin of Asthma and allergic diseases (COCOA) study investigates how genetics and environment impact childhood allergies. Understanding these factors and their interactions is key to preventing pediatric allergic diseases.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Genetics and Epigenetics

Background:

  • Prospective birth-cohort study in Korea (COCOA) focusing on pediatric allergic diseases.
  • Investigates the influence of genetics, perinatal environment, maternal lifestyle, and psychosocial stress.

Purpose of the Study:

  • To determine individual and interactive effects of various factors on susceptibility to pediatric allergic diseases.
  • To explore the causal contribution of environmental variables to the development and course of allergic diseases.
  • To understand how genetics, epigenetics, and early-life exposures interact to shape allergic disease phenotypes.

Main Methods:

  • Recruitment of mother-baby pairs from Seoul, Korea, from 2007-2015.
  • Follow-up assessments from before birth to adolescence, including questionnaires and biological sample collection.
  • Measurement of indoor/outdoor pollutants, maternal stress, nutrition, microbiome, child's genes, and epigenetics.

Main Results:

  • The study design allows for comprehensive data collection on a wide range of potential risk factors.
  • Analysis will focus on identifying key genetic and environmental contributors to allergic diseases.
  • The interactive effects of these factors will be a primary focus of the investigation.

Conclusions:

  • The COCOA study aims to enhance understanding of genetic and environmental risk factors for allergic diseases.
  • It will elucidate the complex interplay between these factors in shaping allergic disease phenotypes.
  • Findings will contribute to improved prevention and management strategies for pediatric allergies.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
38
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K